We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Broccoli Compound Stimulates Immune System in Mouse Model

By Biotechdaily staff writers
Posted on 30 Aug 2007
The indole 3,3'-diindolylmethane (DIM) found in broccoli and related vegetables has been shown in a recent study to be an effective immune system stimulator.

Investigators at the University of California (Berkeley, USA) were following up reports that DIM was able to inhibit the growth of certain types of cancer cells. More...
To this end they studied the overall effect of DIM on the mouse immune system.

The researchers evaluated the results of treatment with DIM in a panel of mouse immune function tests that included splenocyte proliferation, reactive oxygen species (ROS) generation, cytokine production, and resistance to viral infection. Results published in the August 20, 2007, online edition of the Journal of Nutritional Biochemistry revealed that DIM induced proliferation of splenocytes as well as augmented mitogen- and interleukin (IL)-2-induced splenocyte proliferation. DIM also stimulated the production of ROS by mouse macrophage tissue cultures. Oral administration of DIM to the mice, but not intraperitoneal injection, induced elevation of the serum cytokines IL-6, granulocyte colony-stimulating factor (G-CSF), IL-12, and interferon-gamma.

In a model of enteric virus infection, oral DIM administration to mice enhanced both clearance of reovirus from the GI tract and the subsequent mucosal IgA response.

"The effects of DIM were transient, with cytokine and lymphocyte levels going up and then down, which is what you would expect with an immune response,” said senior author, Dr. Leonard Bjeldanes, professor of toxicology at the University of California, Berkeley. "Interestingly, to obtain the effects on the immune response, DIM must be given orally, not injected. We provide clear evidence that DIM is effective in augmenting the immune response for the mice in the study, and we know that the immune system is important in defending the body against infections of many kinds and cancer. This finding bodes well for DIM as a protective agent against major human maladies.”


Related Links:
University of California

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Manual Pipetting Aid
Pipette Controllers macro
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.